Screening Archive

60일이 지난 screening 항목 아카이브입니다. 최근 screening으로 돌아가기.

총 138건.

2026-09-13 (13건)

The management of complex patients with inoperable stage III NSCLC: practical lessons from case-based discussion. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42700509
The changing therapeutic landscape of small-cell lung cancer. — include / 0.95 · Lancet (London, England) · PMID 42702213
Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial. — include / 0.95 · Lancet (London, England) · PMID 42702214
Transcriptomic analysis of a phase 1 trial for intraperitoneal monocytes plus IFNs in ovarian cancer reveals support and recruitment of cell-mediated immunity. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42705863 · 📎 Zotero
TAMing the tumor: targeting immune inhibitory receptors on tumor-associated macrophages in pediatric brain tumors - an emerging immunotherapy strategy. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42705864 · 📎 Zotero
HIF1A+CSF3R+ neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42711068 · 📎 Zotero
Deep learning image reconstruction for 50-keV virtual monoenergetic dual-energy CT of the thyroid: a prospective "dual-low" dose study. — include / 0.92 · European radiology · PMID 42714621
Artificial Intelligence-Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer: An International Multicenter Cohort Study. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42715648 · 📎 Zotero
PRKX-mediated stabilization of PD-L1 characterizes an immunosuppressive gastric cancer subtype. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42716706 · 📎 Zotero
Segmentation-based deep learning emphysema quantification using chest CT: improved accuracy and robustness vs LAA-950. — include / 0.95 · European radiology · PMID 42717029
PREDICT-GBM: A multicenter platform advancing personalized glioblastoma radiotherapy planning. — include / 0.95 · NPJ digital medicine · PMID 42717239 · 📎 Zotero
Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42721617 · 📎 Zotero
The efficacy and feasibility of neoadjuvant immunochemotherapy versus chemotherapy in Limited-Stage Small-Cell lung cancer. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42727356

2026-09-06 (14건)

Enhanced CD33 CAR-NK cells secreting anti-CD73scFv overcome adenosine-mediated immunosuppression and improve anti-AML efficacy. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42680202 · 📎 Zotero
Mechanistic modeling of tumor immune microenvironment reveals strategies to enhance antibody-drug conjugates' efficacy. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42680203 · 📎 Zotero
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer. — include / 0.95 · The New England journal of medicine · PMID 42685317
MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis. — include / 0.95 · Cancer treatment reviews · PMID 42685449
IL20RB drives non-small cell lung cancer progression and immune evasion via K267‑dependent activation of JAK2 phosphorylation and STAT3 signaling. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42685527
Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42686373 · 📎 Zotero
GTPase RAB31 supports ANXA1-driven macrophage education through clathrin-mediated endocytosis to suppress antitumor immunity. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42686375 · 📎 Zotero
Topogram-based anatomical labelling of CT series: anatomy-aware CT data processing using deep learning. — include / 0.92 · European radiology · PMID 42690467 · 📎 Zotero
Clinical outcomes and genomic features of uncommon EGFR exon 19 deletion subtypes in osimertinib-treated non-small cell lung cancer. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42691830
Adjuvant immunotherapy in resectable non-small cell lung cancer with nodal downstaging. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42691831
Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42691832
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42691846 · 📎 Zotero
Artificial intelligence-based assessment of tumor bed stroma in non-small cell lung cancer after neoadjuvant therapy: Association with pathologic response and survival. A multicenter study. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42691847 · 📎 Zotero
Spatial habitat radiomics predicts tertiary lymphoid structure status and identifies an IDO1+ migratory dendritic cell axis in breast cancer. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42692536 · 📎 Zotero

2026-08-30 (6건)

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. — include / 1.00 · The New England journal of medicine · PMID 42212913
Therapeutic evolution: Adoption of newly approved systemic therapies in resected stage IB-IIIA NSCLC in the United States. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42636546
AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42648750 · 📎 Zotero
Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42660015 · 📎 Zotero
Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy. — include / 0.95 · JAMA · PMID 42663420
Adding immunotherapy to chemotherapy may improve survival after SCLC transformation in EGFR-mutant NSCLC: a multicenter real-world study. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42664544

2026-08-23 (4건)

Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42612508
A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42612509 · 📎 Zotero
Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42617307
RaFiST: a radiomics model for non-invasive stratification of tumor fibrosis and prognostic prediction in non-small cell lung cancer. — include / 0.95 · European radiology · PMID 42622885 · 📎 Zotero

2026-08-16 (11건)

Immune signatures in NSCLC associated pleural effusions and implications for prognosis. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42570502 · 📎 Zotero
Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD. — include / 0.95 · Chest · PMID 42586496
PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42586608 · 📎 Zotero
N-glycans in non-malignant tumor microenvironment cells dampen CAR-T cell function in solid tumors. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42586609 · 📎 Zotero
Adapted foundation models for breast MRI triaging in contrast-enhanced and non-contrast-enhanced protocols. — include / 0.92 · European radiology · PMID 42593493 · 📎 Zotero
Turning off methylglyoxal stress: an alternative approach to inhibit MDSC expansion and metastasis in triple-negative breast cancer. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42595355 · 📎 Zotero
ΔAverage of long and short axis diameter on non-contrast CT is associated with major pathological response to neoadjuvant immunotherapy in resectable non-small cell lung cancer. — include / 0.92 · European radiology · PMID 42595861
T cells are critical for pre-metastatic niche formation through the STAT3/IL-17 axis. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42601173 · 📎 Zotero
DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42601174 · 📎 Zotero
AARS1-mediated lactylation reprograms macrophage lipid metabolism to restrict antitumor immunity. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42601175 · 📎 Zotero
Histological aging signatures for monitoring tissue-specific aging and disease. — maybe / 0.65 · Nature medicine · PMID 42601488 · 📎 Zotero

2026-08-09 (9건)

Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42541969
BRAF fusions define therapeutic vulnerability and tyrosine kinase inhibitor resistance in non-small cell lung cancer. — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42546514
Tumor stroma-immune interactions shape the immunosuppressive microenvironment and predict response to neoadjuvant chemoradiotherapy plus immunotherapy in rectal cancer. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42547264 · 📎 Zotero
β-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42552059 · 📎 Zotero
TGF-β1 drives neutrophil extracellular traps formation to promote CD8+ T cell exhaustion via the ERK-c-Fos-JunB axis, mediating gastric cancer immunotherapy resistance. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42552060 · 📎 Zotero
"Yong" syndrome-cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42552062 · 📎 Zotero
Loss of NCCRP1 overcomes immune evasion in lung adenocarcinoma. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42556863 · 📎 Zotero
Targeting GRP75 by natural compound polyphyllin II triggers mitochondrial calcium overload and pyroptosis to potentiate cancer immunotherapy. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42562424 · 📎 Zotero
DAFNet: A multi-modal deep learning model based on whole-lung CT for the automated prediction of the air space spread of lung adenocarcinoma. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42566922

2026-08-02 (3건)

Cancer-associated mesothelial cells drive immune escape and therapy resistance in ovarian cancer. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42532631 · 📎 Zotero
Myosin VI drives breast cancer progression via SP1/CA9-mediated acidic tumor microenvironment remodeling and subsequent M2 macrophage polarization. — include / 0.92 · Journal for immunotherapy of cancer · PMID 42532632 · 📎 Zotero
CPNE1 promotes stemness and confers resistance to GPC3 CAR-T cell therapy in hepatocellular carcinoma via the STAT3-TGF-β signaling pathway. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42538053 · 📎 Zotero

2026-07-30 (7건)

Development and validation of a risk-stratification model for individualized management of leptomeningeal metastases in EGFR- mutant NSCLC (LM-Index). — include / 0.92 · Lung cancer (Amsterdam, Netherlands) · PMID 42501706
Adipocyte-derived LTB4 programs human NKG2A+ γδ T cells as cytotoxic sentinels at the adipose-tumor interface in breast cancer. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42521410 · 📎 Zotero
In situ generation of proinflammatory CAR macrophages via mRNA-TLR agonist co-delivery for triple-negative breast cancer immunotherapy. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42521411 · 📎 Zotero
Pericoronary fat radiomics on coronary CT angiography for predicting major adverse cardiac events: a systematic review and meta-analysis. — include / 0.92 · European radiology · PMID 42521849
Evaluating health-related quality of life questionnaires in capturing common symptomatic adverse events in non-small cell lung cancer. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42526062
IL-27 shapes NK cell heterogeneity and function in colorectal cancer. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42527030
CXCR2-mediated metabolic interaction between prostate cancer cells and the immunosuppressive tumor microenvironment. — include / 0.95 · Journal for immunotherapy of cancer · PMID 42527031

2026-07-25 (8건)

Intratumoral Capnocytophaga leadbetteri promotes cancer cells proliferation and recruits neutrophils by activating TLR4/MyD88/NF-κB axis in oral squamous cell carcinoma. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42481155 · 📎 Zotero
CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42485677
A novel MYO5C-ALK fusion in lung adenocarcinoma: limited alectinib response and durable lorlatinib benefit. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42485678
Therapy-induced senescence rewires the melanoma secretome to promote antitumor immune response and augment cell therapies. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42486609 · 📎 Zotero
Intratumoral TIGIT blockade augments antitumor responses and bypasses increased functionality of peripheral TIGIT+ NK cells in mouse and human models of bone and soft tissue sarcoma. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42486610 · 📎 Zotero
Coronary plaque quantification on energy-integrating and photon-counting detector CT: reproducibility and power modeling for mixed-platform trials. — include / 0.85 · European radiology · PMID 42486966 · 📎 Zotero
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42498485
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42498486

2026-07-22 (13건)

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report. — include / 0.75 · American journal of respiratory and critical care medicine · PMID 42447235
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42448430 · 📎 Zotero
LysoPS-GPR34 axis enhances tumor-associated macrophages efferocytosis to promote immune escape in gastric cancer peritoneal metastasis. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42448431 · 📎 Zotero
Interstitial lung disease in patients treated with antibody-drug conjugates: a review. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42462539
Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42463282 · 📎 Zotero
RAS signaling at the crossroads of radioresistance and tumor immunity. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42468991 · 📎 Zotero
Spatial architecture of tertiary lymphoid structures represents an independent prognostic dimension in hepatocellular carcinoma. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42468992 · 📎 Zotero
Deep learning-based automatic measurement of spinal alignment and implant detection in scoliosis radiographs. — maybe / 0.65 · NPJ digital medicine · PMID 42469410 · 📎 Zotero
A CT-based score for predicting histopathological usual interstitial pneumonia features and predicting disease progression in smokers with fibrotic idiopathic interstitial pneumonia. — include / 0.85 · European radiology · PMID 42470480 · 📎 Zotero
Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42470748
AI-driven tumor heterogeneity quantification and survival prediction in pancreatic ductal adenocarcinoma. — include / 0.90 · NPJ digital medicine · PMID 42477155 · 📎 Zotero
Does OptiTROP-Lung05 open a new frontier for first-line ADC-ICI combinations in NSCLC? — include / 0.90 · Nature reviews. Clinical oncology · PMID 42477498 · 📎 Zotero00889-X/pdf)
Multi-task deep learning model for predicting EGFR mutation status in NSCLC. — include / 0.90 · NPJ digital medicine · PMID 42477500 · 📎 Zotero

2026-07-21 (1건)

Clinical Utility of Next Generation Sequencing in Concurrent EBUS-TBNA and Liquid Biopsies in NSCLC. — include / 0.85 · American journal of respiratory and critical care medicine · PMID 42475517

2026-07-20 (4건)

BCL-2/BCL-xL inhibitor pelcitoclax with osimertinib for EGFR-mutated advanced non-small-cell lung cancer: a phase 1b trial. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42442920 · 📎 Zotero
Outcomes of robotic vs video-assisted thoracoscopic segmentectomy in early-stage NSCLC: A meta-analysis of propensity-matched studies. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42456640
[18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice. — include / 0.85 · European journal of nuclear medicine and molecular imaging · PMID 42463966 · 📎 Zotero
Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT. — include / 0.95 · Lung cancer (Amsterdam, Netherlands) · PMID 42470746

2026-07-13 (45건)

Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trial. — include / 0.75 · European radiology · PMID 41686241
Large language model and Gd-EOB-DTPA-enhanced MRI-based risk stratification system for postoperative hepatocellular carcinoma: a multicenter study. — include / 0.90 · European radiology · PMID 41731093
A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer. — include / 0.92 · Cancer discovery · PMID 41747244 · 📎 Zotero
PET/CT predict pathological response to neoadjuvant nivolumab in resectable non-small cell lung cancer. — include / 0.90 · European journal of nuclear medicine and molecular imaging · PMID 41792564
Evaluating the prognostic impact of multiple 18FDG-PET imaging parameters in small-cell lung cancer: Insights from the long-term analysis of the CONVERT trial. — include / 0.90 · European journal of nuclear medicine and molecular imaging · PMID 41801367 · 📎 Zotero
Beyond whole-image learning: anatomically partitioned deep learning models for superior sinonasal disease classification. — include / 0.85 · European radiology · PMID 41832258 · 📎 Zotero
A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study. — include / 0.92 · European journal of nuclear medicine and molecular imaging · PMID 41870550 · 📎 Zotero
Neuro-visceral immunometabolic network phenotyping via baseline whole-body [¹⁸F]FDG PET/CT underlying pathologic response to neoadjuvant immunochemotherapy in resectable NSCLC. — include / 0.90 · European journal of nuclear medicine and molecular imaging · PMID 41885941 · 📎 Zotero
[177Lu]Lu-DOTA-IBA plus EGFR-TKIs versus [177Lu]Lu-DOTA-IBA monotherapy for EGFR-mutated advanced non-small-cell lung cancer (NSCLC) with bone metastases: a prospective study. — include / 0.90 · European journal of nuclear medicine and molecular imaging · PMID 41915037 · 📎 Zotero
Imaging-based stratification of Claudin 18.2-positive gastric adenocarcinoma using 18F-FDG PET/CT radiomics. — include / 0.90 · European journal of nuclear medicine and molecular imaging · PMID 41942650 · 📎 Zotero
Ternary classification prediction and heterogeneity quantification for HER2-Zero, -low, and -positive in breast cancer using HER2-targeted PET/CT imaging. — include / 0.95 · European journal of nuclear medicine and molecular imaging · PMID 41995838 · 📎 Zotero
Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42066656
Prognostic value of serum CYFRA21-1 in locally advanced non-small cell lung cancer undergoing durvalumab consolidation therapy after chemoradiotherapy. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42066657
Vebreltinib plus EGFR-TKI for EGFR-mutated NSCLC with MET-driven resistance: A real-world study of Chinese patients. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42068890 · 📎 Zotero
Clinical impact of local consolidative therapy in EGFR-mutant metastatic NSCLC: A propensity-matched multicenter analysis. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42068892 · 📎 Zotero
Protective effect of bevacizumab against interstitial lung disease in non-squamous non-small-cell lung cancer: a nationwide target trial emulation study. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42081857
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion). — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42096800 · 📎 Zotero
Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42114373 · 📎 Zotero
Insights from a randomized controlled trial on a digital lifestyle intervention in non-small cell lung cancer survivors following inpatient rehabilitation. — maybe / 0.65 · Lung cancer (Amsterdam, Netherlands) · PMID 42127533 · 📎 Zotero
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42127534
Final overall survival analysis of the APPLE study: atezolizumab and platinum-pemetrexed with or without bevacizumab for metastatic nonsquamous non-small cell lung cancer. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42127535 · 📎 Zotero
Comparative effectiveness of first-line targeted therapies in ALK-positive non-small cell lung cancer: real-world evidence of tyrosine kinase inhibitors. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42134157
An interpretable PET/CT-based radiomic-clinical model for predicting bone marrow involvement in follicular lymphoma: comparison of pelvic and spine-pelvis VOI frameworks. — include / 0.92 · European journal of nuclear medicine and molecular imaging · PMID 42142271
Patient and clinician preferences for adjuvant treatment following surgical resection in early-stage non-small cell lung cancer: A multi-country discrete choice experiment. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42143519 · 📎 Zotero
Patient and caregiver priorities of treatment characteristics influencing preferences for tyrosine kinase inhibitors in anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42143874 · 📎 Zotero
OX40+ regulatory T cells suppress neoadjuvant chemotherapy response in NSCLC and reversed by combination of PD-1 blockade therapy. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42150482
Docetaxel plus ramucirumab immediately after immunotherapy in advanced NSCLC: A phase II study (DRUN). — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42150483 · 📎 Zotero00515-5/pdf)
Phase Ib of repotrectinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42155306
Clinical characteristics and survival of small cell lung cancer with limited or extensive synchronous metastatic spread - A German population-based cancer-registry based cohort study. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42167027 · 📎 Zotero00509-X/pdf)
Study on NGS-based molecular profiling of malignant pleural effusion supernatant cfDNA in guiding targeted therapy for non-small cell lung cancer. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42172737 · 📎 Zotero
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42214242
Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42214243
Rare EGFRm NSCLC: More First-Line Options Emerge. — include / 0.90 · Cancer discovery · PMID 42224429
Selpercatinib Improves EFS in RET Fusion-Positive NSCLC. — include / 0.95 · Cancer discovery · PMID 42226675
Real-world comparative effectiveness of sotorasib versus docetaxel monotherapy in second line and beyond for advanced or metastatic non-small cell lung cancer: A national database analysis from England. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42229337 · 📎 Zotero
Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42229338
Reply to Qu et al.: Do mtDNA fragmentomic peaks reflect cancer biology or preanalytical and technical artifacts in NSCLC? — include / 0.85 · American journal of respiratory and critical care medicine · PMID 42391029
Do mtDNA fragmentomic peaks reflect cancer biology or preanalytical and technical artifacts in NSCLC? — include / 0.85 · American journal of respiratory and critical care medicine · PMID 42393493
Clonal divergence with acquired BRAF V600E in NSCLC with compound EGFR G719X/S768I after prolonged EGFR-TKI therapy. — include / 0.85 · Lung cancer (Amsterdam, Netherlands) · PMID 42398475 · 📎 Zotero
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model. — include / 0.90 · Lung cancer (Amsterdam, Netherlands) · PMID 42407241
Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer. — include / 0.90 · JAMA · PMID 42418196
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer. — include / 0.95 · The New England journal of medicine · PMID 42418775
Clinical significance of CD161+CD8+ T cells in the tumor microenvironment of esophageal squamous cell carcinoma and their association with the 4-1BB signaling pathway. — include / 0.85 · Journal for immunotherapy of cancer · PMID 42425714 · 📎 Zotero
Plasma proteomics predicts pathological complete response and reveals LIF as a potential mediator of resistance to neoadjuvant immunochemotherapy in resectable NSCLC. — include / 0.90 · Journal for immunotherapy of cancer · PMID 42425715 · 📎 Zotero
From center to edge: Prognostic implications of spatial metabolic heterogeneity, normalized hotspot-to-centroid and perimeter distance, on PET imaging. A systematic review and meta-analysis. — include / 0.90 · European journal of nuclear medicine and molecular imaging · PMID 42429822